featured
Effects of Empagliflozin on Cardiovascular and Kidney Outcomes Irrespective of DKD Categories
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Consistent Effects of Empagliflozin on Cardiovascular and Kidney Outcomes Irrespective of Diabetic Kidney Disease Categories — Insights From the EMPA-REG OUTCOME Trial
Diabetes Obes Metab 2020 Aug 03;[EPub Ahead of Print], C Wanner, SE Inzucchi, B Zinman, A Koitka-Weber, MMD Biomath, JT George, M von Eynatten, SJ HauskeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.